<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02046005</url>
  </required_header>
  <id_info>
    <org_study_id>P60 AR047782-6121</org_study_id>
    <secondary_id>P60AR047782</secondary_id>
    <nct_id>NCT02046005</nct_id>
  </id_info>
  <brief_title>Personalized Risk Estimator for Rheumatoid Arthritis Family Study</brief_title>
  <acronym>PRE-RA</acronym>
  <official_title>Communication of Biomarker, Genetic, and Lifestyle Risk Factor Profiles for Rheumatoid Arthritis to First Degree Relatives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to understand how personalized risk factors for rheumatoid
      arthritis (RA) may impact willingness to change behaviors associated with RA. The
      investigators have developed a personalized risk estimator for RA based on demographics,
      family history, biomarkers and behaviors related to RA risk. Eligible participants have a
      first degree relative with RA but do not have RA themselves. Participants who meet
      eligibility and consent to the study will be randomized to receive either standard
      information about RA, the online personalized RA risk tool, or the online personalized RA
      risk tool with guidance from a health educator. Participants will be followed to measure
      willingness to change RA risk behaviors. The investigators hypothesize that participants who
      receive the online personalized RA risk tool and health education will be more willing to
      change RA risk behaviors compared to participants that receive standard RA information.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A risk tool for rheumatoid arthritis (RA) was developed to provide personalized risk
      communication that includes biomarker, genetic and lifestyle RA risk factors. This risk
      calculator is referred to as the Personalized Risk Estimator for Rheumatoid Arthritis
      (PRE-RA) which will be used in the PRE-RA Family Study. A 3-arm randomized trial will be
      conducted among 222 RA first degree relatives that will be followed for one year.
      Participants will be surveyed before and after RA education concerning (i) knowledge and
      attitudes about RA risk, (ii) decisional balance related to behaviors, and (iii) stage of
      behavior change concerning lifestyle risks.

      At the initial study visit, participants will be randomly assigned to one of three arms. Arm
      1 participants will receive general education about RA (comparison group). These participants
      will be followed to assess for willingness to change behaviors associated with RA risk. Arm 2
      participants will receive personalized risk by the personalized RA risk tool (PRE-RA). These
      participants will be followed to assess for willingness to change RA risk behaviors. Arm 3
      participants will receive personalized risk by the online risk tool along with health
      education and counseling (PRE-RA Plus group). These participants will be followed to assess
      for willingness to change RA risk behaviors.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Actual">July 2018</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Contemplation Ladder</measure>
    <time_frame>Immediately, 6 weeks, and 6 months after intervention</time_frame>
    <description>Measures willingness to change any of 4 RA-related behaviors compared to baseline using generalized estimating equations to compare the PRE-RA groups to the comparison arm.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">238</enrollment>
  <condition>First Degree Relatives of Rheumatoid Arthritis Patients</condition>
  <arm_group>
    <arm_group_label>General Rheumatoid Arthritis Education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm 1 participants will receive general information about RA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PRE-RA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm 2 participants will receive personalized RA risk education by the PRE-RA risk tool.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PRE-RA Plus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm 3 participants will receive personalized RA risk education by the PRE-RA risk tool and health educator.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PRE-RA</intervention_name>
    <description>Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) is an online tool that provides education about RA, collects data about demographics and behaviors, and presents personalized RA risk information.</description>
    <arm_group_label>PRE-RA</arm_group_label>
    <other_name>Personalized Risk Estimator for RA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PRE-RA Plus</intervention_name>
    <description>Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) is an online tool that provides education about RA, collects data about demographics and behaviors, and presents personalized RA risk information. In addition, participants in this arm receive education from a health educator.</description>
    <arm_group_label>PRE-RA Plus</arm_group_label>
    <other_name>Personalized Risk Estimator for RA with Health Educator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>General Rheumatoid Arthritis Education</intervention_name>
    <description>Participants will receive general information about signs and symptoms of rheumatoid arthritis.</description>
    <arm_group_label>General Rheumatoid Arthritis Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First degree blood relative (parent, sibling, or child) with diagnosis of RA

          -  Age between 18 and 70 years old

        Exclusion Criteria:

          -  Non-English speaking

          -  Sign/symptoms of rheumatoid arthritis (assessed by screening questionnaire and study
             staff)

          -  Rheumatoid arthritis

          -  Systemic lupus erythematosus

          -  Juvenile Idiopathic Arthritis

          -  Psoriatic Arthritis

          -  Ankylosing Spondylitis

          -  Mixed Connective Tissue Disease

          -  Reactive Arthritis

          -  Adult-Onset Still's Disease

          -  Sjogren's Syndrome

          -  Dermatomyositis

          -  Polymyositis

          -  Polymyalgia Rheumatica

          -  ANCA-associated Vasculitis

          -  Giant Cell Arteritis

          -  Polyarteritis Nodosa

          -  Behcet's Disease

          -  Relapsing Polychondritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth W Karlson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sparks JA, Iversen MD, Miller Kroouze R, Mahmoud TG, Triedman NA, Kalia SS, Atkinson ML, Lu B, Deane KD, Costenbader KH, Green RC, Karlson EW. Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) Family Study: rationale and design for a randomized controlled trial evaluating rheumatoid arthritis risk education to first-degree relatives. Contemp Clin Trials. 2014 Sep;39(1):145-57. doi: 10.1016/j.cct.2014.08.007. Epub 2014 Aug 20.</citation>
    <PMID>25151341</PMID>
  </reference>
  <results_reference>
    <citation>Sparks JA, Iversen MD, Yu Z, Triedman NA, Prado MG, Miller Kroouze R, Kalia SS, Atkinson ML, Mody EA, Helfgott SM, Todd DJ, Dellaripa PF, Bermas BL, Costenbader KH, Deane KD, Lu B, Green RC, Karlson EW. Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2018 Jun;70(6):823-833. doi: 10.1002/acr.23411. Epub 2018 Apr 16.</citation>
    <PMID>29024454</PMID>
  </results_reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>January 23, 2014</study_first_submitted>
  <study_first_submitted_qc>January 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2014</study_first_posted>
  <results_first_submitted>January 16, 2018</results_first_submitted>
  <results_first_submitted_qc>May 8, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">June 7, 2018</results_first_posted>
  <last_update_submitted>July 12, 2018</last_update_submitted>
  <last_update_submitted_qc>July 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Elizabeth Karlson, M.D.</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Family History</keyword>
  <keyword>RA</keyword>
  <keyword>Rheumatoid Arthritis</keyword>
  <keyword>Genetics</keyword>
  <keyword>Rheumatoid Factor</keyword>
  <keyword>Shared Epitope</keyword>
  <keyword>Anti-CCP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>General Rheumatoid Arthritis Education</title>
          <description>Arm 1 participants will receive general information about RA.
General Rheumatoid Arthritis Education: Participants will receive general information about signs and symptoms of rheumatoid arthritis.</description>
        </group>
        <group group_id="P2">
          <title>PRE-RA</title>
          <description>Arm 2 participants will receive personalized RA risk education by the PRE-RA risk tool.
PRE-RA: Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) is an online tool that provides education about RA, collects data about demographics and behaviors, and presents personalized RA risk information.</description>
        </group>
        <group group_id="P3">
          <title>PRE-RA Plus</title>
          <description>Arm 3 participants will receive personalized RA risk education by the PRE-RA risk tool and health educator.
PRE-RA Plus: Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) is an online tool that provides education about RA, collects data about demographics and behaviors, and presents personalized RA risk information. In addition, participants in this arm receive education from a health educator.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="80"/>
                <participants group_id="P2" count="78"/>
                <participants group_id="P3" count="80"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="72"/>
                <participants group_id="P2" count="71"/>
                <participants group_id="P3" count="70"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>General Rheumatoid Arthritis Education</title>
          <description>Arm 1 participants will receive general information about RA.
General Rheumatoid Arthritis Education: Participants will receive general information about signs and symptoms of rheumatoid arthritis.</description>
        </group>
        <group group_id="B2">
          <title>PRE-RA</title>
          <description>Arm 2 participants will receive personalized RA risk education by the PRE-RA risk tool.
PRE-RA: Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) is an online tool that provides education about RA, collects data about demographics and behaviors, and presents personalized RA risk information.</description>
        </group>
        <group group_id="B3">
          <title>PRE-RA Plus</title>
          <description>Arm 3 participants will receive personalized RA risk education by the PRE-RA risk tool and health educator.
PRE-RA Plus: Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) is an online tool that provides education about RA, collects data about demographics and behaviors, and presents personalized RA risk information. In addition, participants in this arm receive education from a health educator.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="80"/>
            <count group_id="B2" value="78"/>
            <count group_id="B3" value="80"/>
            <count group_id="B4" value="238"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.4" spread="14.7"/>
                    <measurement group_id="B2" value="45.0" spread="14.9"/>
                    <measurement group_id="B3" value="48.3" spread="13.7"/>
                    <measurement group_id="B4" value="45.6" spread="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="57"/>
                    <measurement group_id="B4" value="182"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="73"/>
                    <measurement group_id="B4" value="207"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Contemplation Ladder</title>
        <description>Measures willingness to change any of 4 RA-related behaviors compared to baseline using generalized estimating equations to compare the PRE-RA groups to the comparison arm.</description>
        <time_frame>Immediately, 6 weeks, and 6 months after intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>General Rheumatoid Arthritis Education</title>
            <description>Arm 1 participants will receive general information about RA.
General Rheumatoid Arthritis Education: Participants will receive general information about signs and symptoms of rheumatoid arthritis.</description>
          </group>
          <group group_id="O2">
            <title>PRE-RA</title>
            <description>Arm 2 participants will receive personalized RA risk education by the PRE-RA risk tool.
PRE-RA: Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) is an online tool that provides education about RA, collects data about demographics and behaviors, and presents personalized RA risk information.</description>
          </group>
          <group group_id="O3">
            <title>PRE-RA Plus</title>
            <description>Arm 3 participants will receive personalized RA risk education by the PRE-RA risk tool and health educator.
PRE-RA Plus: Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) is an online tool that provides education about RA, collects data about demographics and behaviors, and presents personalized RA risk information. In addition, participants in this arm receive education from a health educator.</description>
          </group>
        </group_list>
        <measure>
          <title>Contemplation Ladder</title>
          <description>Measures willingness to change any of 4 RA-related behaviors compared to baseline using generalized estimating equations to compare the PRE-RA groups to the comparison arm.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="78"/>
                <count group_id="O3" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Immediately post-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="46"/>
                    <measurement group_id="O3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 weeks post-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="49"/>
                    <measurement group_id="O3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="53"/>
                    <measurement group_id="O3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>In the primary analysis, we combined the PRE-RA and PRE-RA Plus arms into a single &quot;PRE-RA group&quot; and compared it to the Comparison arm (aka &quot;General Rheumatoid Arthritis Education&quot;)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.043</p_value>
            <p_value_desc>We compared the PRE-RA group (PRE-RA arm and PRE-RA Plus arm combined) to the Comparison arm for the primary composite outcome at the 3 primary post-intervention time points using generalized estimating equations (GEE).</p_value_desc>
            <method>generalized estimating equations</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.23</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.01</ci_lower_limit>
            <ci_upper_limit>1.51</ci_upper_limit>
            <estimate_desc>PRE-RA group (combined PRE-RA arm and PRE-RA Plus arm) compared to Comparison arm (reference)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>Behavioral intervention</desc>
      <group_list>
        <group group_id="E1">
          <title>General Rheumatoid Arthritis Education</title>
          <description>Arm 1 participants will receive general information about RA.
General Rheumatoid Arthritis Education: Participants will receive general information about signs and symptoms of rheumatoid arthritis.</description>
        </group>
        <group group_id="E2">
          <title>PRE-RA</title>
          <description>Arm 2 participants will receive personalized RA risk education by the PRE-RA risk tool.
PRE-RA: Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) is an online tool that provides education about RA, collects data about demographics and behaviors, and presents personalized RA risk information.</description>
        </group>
        <group group_id="E3">
          <title>PRE-RA Plus</title>
          <description>Arm 3 participants will receive personalized RA risk education by the PRE-RA risk tool and health educator.
PRE-RA Plus: Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) is an online tool that provides education about RA, collects data about demographics and behaviors, and presents personalized RA risk information. In addition, participants in this arm receive education from a health educator.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="80"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Elizabeth Karlson</name_or_title>
      <organization>Brigham and Women's Hospital</organization>
      <phone>617-732-5078</phone>
      <email>ekarlson@bwh.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

